首页> 美国卫生研究院文献>Pulmonary Circulation >Metabolism of asymmetric dimethylarginine in hypoxia: from bench to bedside
【2h】

Metabolism of asymmetric dimethylarginine in hypoxia: from bench to bedside

机译:缺氧中不对称二甲基碱的代谢:从长凳到床边

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Acute hypoxia and chronic hypoxia induce pulmonary vasoconstriction. While hypoxic pulmonary vasoconstriction is a physiological response if parts of the lung are affected, global exposure to hypoxic conditions may lead to clinical conditions like high-altitude pulmonary hypertension. Nitric oxide is the major vasodilator released from the vascular endothelium. Nitric oxide-dependent vasodilation is impaired in hypoxic conditions. Inhibition of nitric oxide synthesis is the most rapid and easily reversible molecular mechanism to regulate nitric oxide-dependent vascular function in response to physiological and pathophysiological stimuli. Asymmetric dimethylarginine is an endogenous, competitive inhibitor of nitric oxide synthase and a risk marker for major cardiovascular events and mortality. Elevated asymmetric dimethylarginine has been observed in animal models of hypoxia as well as in human cohorts under chronic and chronic intermittent hypoxia at high altitude. In lowlanders, asymmetric dimethylarginine is high in patients with pulmonary hypertension. We have recently shown that high asymmetric dimethylarginine at sea level is a predictor for high-altitude pulmonary hypertension. Asymmetric dimethylarginine is a highly regulated molecule, both by its biosynthesis and metabolism. Methylation of L-arginine by protein arginine methyltransferases was shown to be increased in hypoxia. Furthermore, the metabolism of asymmetric dimethylarginine by dimethylarginine dimethylaminohydrolases (DDAH1 and DDAH2) is decreased in animal models of hypoxia. Whether these changes are caused by transcriptional or posttranslational modifications remains to be elucidated. Current data suggest a major role of asymmetric dimethylarginine in regulating pulmonary arterial nitric oxide production in hypoxia. Further studies are needed to decipher the molecular mechanisms regulating asymmetric dimethylarginine in hypoxia and to understand their clinical significance.
机译:急性缺氧和慢性缺氧诱导肺血管收缩。虽然缺氧肺癌是一种生理反应,但如果肺部的部分受到影响,则全球暴露于缺氧条件可能导致高海拔肺动脉高压等临床条件。一氧化氮是从血管内皮释放的主要血管扩张器。在缺氧条件下损害一氧化氮依赖性血管抑制。抑制一氧化氮合成是最迅速且易于可逆的分子机制,以响应生理和病理生理刺激来调节一氧化氮依赖性血管功能。不对称二甲基尿苷是一氧化氮合酶的内源性竞争性抑制剂和用于主要心血管事件和死亡率的风险标志物。在缺氧的缺氧和慢性和慢性间歇性缺氧下的动物模型中观察到升高的非对称二甲基碱,在高海拔地区的慢性和慢性间歇性缺氧。在Lowlanders中,肺动脉高压患者的不对称二甲基尿苷。我们最近显示海平面的高不对称二甲基碱是高海拔肺动脉高压的预测因子。不对称二甲基尿苷是一种高度调节的分子,既通过其生物合成和代谢。通过蛋白质精氨酸甲基转移酶的L-精氨酸的甲基化被显示在缺氧中增加。此外,在缺氧的动物​​模型中,二甲基喹硫氨酸二甲基氨基水解酶(DDAH1和DDAH2)的非对称二甲基喹啉的代谢降低。这些变化是由转录或后期修改引起的仍有待阐明的。目前的数据表明了不对称二甲基碱在调节缺氧中肺动脉一氧化氮产生方面的主要作用。需要进一步研究来破译调节缺氧中不对称二甲基碱的分子机制,并了解其临床意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号